pharmaphorum

JUNE 8, 2021

“Now, we’ll wait a decade before it becomes obvious to everyone that there are no benefits – only high healthcare costs – associated with the treatment,” said Howard. Analysts at GlobalData think that Biogen will have challenges rolling out Aduhelm in the US, but are still predicting sales of $5.6 billion in 2027.

FDA 98

FDA Labelling 98

Pharmaceutical Technology

APRIL 24, 2023

Having steadily risen over the last two decades, 2020 saw more approvals for biopharmaceuticals, often termed as biologics, than any other year in the last decade, according to GlobalData analysis. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures.

Vaccines 52

Vaccines Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Insurance 105

Insurance Labelling Communication FDA 105

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Insurance 98

Insurance Labelling Communication FDA 98

Pharmaceutical Technology

FEBRUARY 6, 2023

According to GlobalData, there are 25 marketed drugs for IPF available in North America. GlobalData is the parent company of Pharmaceutical Technology. According to GlobalData, 29 drugs are currently marketed for managing the complications of PSC, but none can reverse liver damage associated with PSC.

FDA 59

FDA Pharmaceutical Companies Pharmaceutical Companies Communication 59